RxDoctor Payments Data

Craig Schwartz, MD

Physical Medicine & Rehabilitation · Clearwater, FLNPI 1447229828

Payments from drug & device makers

$1,106in general payments, 2019–2025

Across 52 payments — averaging $21.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$472
  • Scilex Pharmaceuticals Inc.$152
  • Radius Health, Inc.$141
  • Johnson & Johnson$82
  • Orthofix Medical, Inc.$67
  • Endo Pharmaceuticals Inc.$41
  • plus $151 from 7 others

What the payments were for

  • Food & beverage$1,07897%
  • Education$283%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)21$472
Scilex Pharmaceuticals Inc.8$152
Radius Health, Inc.7$141
Johnson & Johnson3$82
Orthofix Medical, Inc.3$67
Endo Pharmaceuticals Inc.2$41
Bioventus LLC2$33
Stryker1$30
Acumed LLC1$21
Coastal Medical Technologies LLC1$19
Ultragenyx Pharmaceutical Inc.1$17
ERMI LLC1$16
Theragen, Inc.1$15

How this compares

$1,106 in reported general payments places this provider in the 75th percentile of 618 physical medicine & rehabilitation providers in Florida.

See all physical medicine & rehabilitation providers in Florida

Medicare billing

Part B allowed, 2024
$274,852
Medicare patients
542
Services billed
6,630

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ProliaDenosumab33$57,580
Gabapentin240$1,483
Baclofen93$620
Methylprednisolone88$565
Tizanidine Hcl101$564
Meloxicam137$249
Celecoxib13$227
Alendronate Sodium36$215
Pregabalin13$163
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen20$111
Methocarbamol30$76
Omeprazole40$74
Cyclobenzaprine Hcl16$61
Tramadol Hcl26$56

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenProlia$472$57,58033 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 618 physical medicine & rehabilitation providers in Florida.

Other physical medicine & rehabilitation in Clearwater

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →